Table 1
Initial Key Evidence Table
| Key Evidence | Measure Type |
| Prevalence of background retinopathy | % |
| Screening rate | % |
| Diabetic retinopathy incidence | % |
| Screening cost | $/screening |
| Screening sensitivity | % |
| Screening specificity | % |
| Treatment rate | % |
| Treatment cost | $/procedure |
| Treatment success rate | % |
| Annual untreated blindness rate | % |
| Annual blindness cost | $ |
| Quality-adjusted life years for blindness | Fraction of year |
It is useful to construct a key evidence table to guide the literature review and evidence synthesis process. Shown here is the initial key evidence table for the diabetic eye disease bridging model.
